BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31439257)

  • 21. Diffusion-weighted magnetic resonance imaging of ovarian tumors: differentiation of benign and malignant solid components of ovarian masses.
    Takeuchi M; Matsuzaki K; Nishitani H
    J Comput Assist Tomogr; 2010; 34(2):173-6. PubMed ID: 20351498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apparent diffusion coefficient ratio correlates significantly with prostate cancer gleason score at final pathology.
    Boesen L; Chabanova E; Løgager V; Balslev I; Thomsen HS
    J Magn Reson Imaging; 2015 Aug; 42(2):446-53. PubMed ID: 25408104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved performance in differentiating benign from malignant sinonasal tumors using diffusion-weighted combined with dynamic contrast-enhanced magnetic resonance imaging.
    Wang XY; Yan F; Hao H; Wu JX; Chen QH; Xian JF
    Chin Med J (Engl); 2015 Mar; 128(5):586-92. PubMed ID: 25698188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrioid adenocarcinoma of the ovary: MRI findings with emphasis on diffusion-weighted imaging for the differentiation of ovarian tumors.
    Kovač JD; Terzić M; Mirković M; Banko B; Đikić-Rom A; Maksimović R
    Acta Radiol; 2016 Jun; 57(6):758-66. PubMed ID: 26307063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of diffusion-weighted imaging combined with conventional magnetic resonance imaging in the diagnosis of thecomas and their differential diagnosis with adult granulosa cell tumors.
    Fang M; Dong J; Zhong Q; Fang X; Chen Y; Wang C; Yan H
    Acta Radiol; 2019 Nov; 60(11):1532-1542. PubMed ID: 30776906
    [No Abstract]   [Full Text] [Related]  

  • 26. The value of MRI for differentiating benign from malignant sex cord-stromal tumors of the ovary: emphasis on diffusion-weighted MR imaging.
    Zhao SH; Li HM; Qiang JW; Wang DB; Fan H
    J Ovarian Res; 2018 Aug; 11(1):73. PubMed ID: 30165895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffusion MRI of uterine and ovarian masses: identifying the benign lesions.
    Davarpanah AH; Kambadakone A; Holalkere NS; Guimaraes AR; Hahn PF; Lee SI
    Abdom Radiol (NY); 2016 Dec; 41(12):2466-2475. PubMed ID: 27660280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADC-derived spatial features can accurately classify adnexal lesions.
    Fathi Kazerooni A; Nabil M; Haghighat Khah H; Alviri M; Heidari-Sooreshjaani M; Gity M; Malek M; Saligheh Rad H
    J Magn Reson Imaging; 2018 Apr; 47(4):1061-1071. PubMed ID: 28901638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solid bone tumors of the spine: Diagnostic performance of apparent diffusion coefficient measured using diffusion-weighted MRI using histology as a reference standard.
    Pozzi G; Albano D; Messina C; Angileri SA; Al-Mnayyis A; Galbusera F; Luzzati A; Perrucchini G; Scotto G; Parafioriti A; Zerbi A; Sconfienza LM
    J Magn Reson Imaging; 2018 Apr; 47(4):1034-1042. PubMed ID: 28755383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusion-Weighted Magnetic Resonance Imaging (DWI) Parameters in Benign and Malignant Ovarian Tumors with Solid and Cystic Components.
    Zhuang Y; Wang T; Zhang G
    J Coll Physicians Surg Pak; 2019 Feb; 29(2):105-108. PubMed ID: 30700345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Value of Diffusion-Weighted Imaging in the Differential Diagnosis of Ovarian Lesions: A Meta-Analysis.
    Kim HJ; Lee SY; Shin YR; Park CS; Kim K
    PLoS One; 2016; 11(2):e0149465. PubMed ID: 26907919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion-weighted MRI: a useful technique to discriminate benign versus malignant ovarian surface epithelial tumors with solid and cystic components.
    Li W; Chu C; Cui Y; Zhang P; Zhu M
    Abdom Imaging; 2012 Oct; 37(5):897-903. PubMed ID: 22038329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between types I and II epithelial ovarian cancer using histogram analysis of monoexponential, biexponential, and stretched-exponential diffusion models.
    Wang F; Wang Y; Zhou Y; Liu C; Xie L; Zhou Z; Liang D; Shen Y; Yao Z; Liu J
    J Magn Reson Imaging; 2017 Dec; 46(6):1797-1809. PubMed ID: 28379611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative evaluation of the relative apparent diffusion coefficient values on multiparametric magnetic resonance imaging to predict higher Gleason score prostate cancer.
    Kato S; Kamijima S; Inaoka T; Kamiya N; Sasai D; Terada H; Hiruta N; Suzuki H
    Scand J Urol; 2018 Jun; 52(3):180-185. PubMed ID: 29939084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions.
    Fujii S; Kakite S; Nishihara K; Kanasaki Y; Harada T; Kigawa J; Kaminou T; Ogawa T
    J Magn Reson Imaging; 2008 Nov; 28(5):1149-56. PubMed ID: 18972356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of magnetic resonance imaging to differentiate between borderline and malignant serous epithelial ovarian tumors.
    Akçay A; Peker AA; Oran Z; Toprak H; Toluk Ö; Balsak S; Badur BA; Gültekin MA
    Abdom Radiol (NY); 2024 Jan; 49(1):229-236. PubMed ID: 37857912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic value of diffusion-weighted magnetic resonance imaging: differentiation of benign and malignant lymph nodes in different regions of the body.
    Seber T; Caglar E; Uylar T; Karaman N; Aktas E; Aribas BK
    Clin Imaging; 2015; 39(5):856-62. PubMed ID: 26091745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value of the apparent diffusion coefficient in diffusion weighted imaging at 3.0T MR for differentiating lacrimal gland tumors].
    Wang YZ; Xian JF; Yang BT; Guo J; Wang XY; Song LY
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(1):53-56. PubMed ID: 30641666
    [No Abstract]   [Full Text] [Related]  

  • 39. High-Resolution Diffusion-Weighted Imaging Improves the Diagnostic Accuracy of Dynamic Contrast-Enhanced Sinonasal Magnetic Resonance Imaging.
    Wang F; Sha Y; Zhao M; Wan H; Zhang F; Cheng Y; Tang W
    J Comput Assist Tomogr; 2017; 41(2):199-205. PubMed ID: 27560026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of Seromucinous Borderline Tumor from Serous Borderline Tumor on MR Imaging.
    Kurata Y; Kido A; Moribata Y; Kameyama K; Minamiguchi S; Konishi I; Togashi K
    Magn Reson Med Sci; 2018 Jul; 17(3):211-217. PubMed ID: 28993546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.